Wu JM, Vaughan CP, Goode PS, et al. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol. 2014 Jan;123(1):141–8. doi: 10.1097/aog.0000000000000057. PMID: 24463674. [PMC free article: PMC3970401] [PubMed: 24463674] [CrossRef]

Qaseem A, Dallas P, Forciea MA, et al. Nonsurgical management of urinary incontinence in women: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014 Sep 16;161(6):429–40. doi: 10.7326/m13-2410. PMID: 25222388. [PubMed: 25222388] [CrossRef]

Ganz ML, Smalarz AM, Krupski TL, et al. Economic costs of overactive bladder in the United States. Urology. 2010 Mar;75(3):526–32, 32.e1–18. doi: 10.1016/j.urology.2009.06.096. PMID: 20035977. [PubMed: 20035977] [CrossRef]

Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4–20. doi: 10.1002/nau.20798. PMID: 19941278. [PubMed: 19941278] [CrossRef]

U.S. Preventive Services Task Force. Procedure Manual.; December 2015. https://www​.uspreventiveservicestaskforce​.org/Page/Name/methods-and-processes. Accessed on January 11, 2017.

AHRQ Methods for Effective Health Care. Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011.

NICE Clinical guideline [CG171]. Urinary incontinence in women: management. UK: National Institute for Health and Care Excellence; 2015. https://www​.nice.org.uk/guidance/cg171.

Gormley EA, Lightner DJ, Burgio KL, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. The Journal of urology. 2012;188(6):2455–63. [PubMed: 23098785]

Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj. 2011 Oct 18;343:d5928. doi: 10.1136/bmj.d5928. PMID: 22008217. [PMC free article: PMC3196245] [PubMed: 22008217] [CrossRef]

Wells GAS, B.;O’Connell, D.;Peterson, J.; Welch, V.; Losos, M.; Tugwell, P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www​.ohri.ca/programs​/clinical_epidemiology/oxford.asp.

Berkman ND, Lohr KN, Ansari M, et al. AHRQ Methods for Effective Health Care: Grading the Strength of a Body of Evidence When Assessing Health Care Interventions for the Effective Health Care Program of the Agency for Healthcare Research and Quality: An Update. Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Rockville (MD): Agency for Healthcare Research and Quality (US); 2008. [PubMed: 24404627]

Coyne KS, Sexton CC, Kopp Z, et al. Assessing patients’ descriptions of lower urinary tract symptoms (LUTS) and perspectives on treatment outcomes: results of qualitative research. Int J Clin Pract. 2010 Aug;64(9):1260–78. doi: 10.1111/j.1742-1241.2010.02450.x. PMID: 20579138. [PubMed: 20579138] [CrossRef]

Heisen M, Baeten SA, Verheggen BG, et al. Patient and physician preferences for oral pharmacotherapy for overactive bladder: two discrete choice experiments. Curr Med Res Opin. 2016;32(4):787–96. doi: 10.1185/03007995.2016.1142959. PMID: 26789823. [PubMed: 26789823] [CrossRef]

Kim H, Yoshida H, Suzuki T. Effects of exercise treatment with or without heat and steam generating sheet on urine loss in community-dwelling Japanese elderly women with urinary incontinence. Geriatr Gerontol Int. 2011 Oct;11(4):452–9. doi: 10.1111/j.1447-0594.2011.00705.x. PMID: 21545385. [PubMed: 21545385] [CrossRef]

AUGS Consensus Statement: Association of Anticholinergic Medication Use and Cognition in Women With Overactive Bladder. Female Pelvic Med Reconstr Surg. 2017 May/Jun;23(3):177–8. doi: 10.1097/spv.0000000000000423. PMID: 28441276. [PubMed: 28441276] [CrossRef]

Hartmann KE, McPheeters ML, Biller DH, et al. Treatment of overactive bladder in women. Evid Rep Technol Assess (Full Rep). 2009 Aug(187):1–120, v. PMID: 19947666. [PMC free article: PMC4781496] [PubMed: 19947666]

Burgio KL, Kraus SR, Menefee S, et al. Behavioral therapy to enable women with urge incontinence to discontinue drug treatment: a randomized trial. Ann Intern Med. 2008 Aug 05;149(3):161–9. PMID: 18678843. [PMC free article: PMC3201984] [PubMed: 18678843]

Yu YF, Nichol MB, Yu AP, et al. Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the california medicaid program. Value Health. 2005 Jul-Aug;8(4):495–505. doi: 10.1111/j.1524-4733.2005.00041.x. PMID: 16091027. [PubMed: 16091027] [CrossRef]

Shamliyan T, Wyman J, Kane RL. AHRQ Comparative Effectiveness Reviews. Nonsurgical Treatments for Urinary Incontinence in Adult Women: Diagnosis and Comparative Effectiveness. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012. [PubMed: 22624162]

Shamliyan T, Wyman J, Bliss DZ, et al. Prevention of urinary and fecal incontinence in adults. Evid Rep Technol Assess (Full Rep). 2007 Dec(161):1–379. PMID: 18457475. [PMC free article: PMC4781595] [PubMed: 18457475]

Shamliyan TA, Kane RL, Wyman J, et al. Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med. 2008 Mar 18;148(6):459–73. PMID: 18268288. [PubMed: 18268288]

Neuromodulation, or Neuromodulatory Effect. San Francisco, CA: International Neuromodulation Society; 2018. http://www​.neuromodulation​.com/neuromodulation-defined.

Sung VW, Marques F, Rogers RR, et al. Content validation of the patient-reported outcomes measurement information system (PROMIS) framework in women with urinary incontinence. Neurourol Urodyn. 2011 Apr;30(4):503–9. doi: 10.1002/nau.21048. PMID: 21400574. [PMC free article: PMC4116099] [PubMed: 21400574] [CrossRef]

Lee KS, Lee YS, Kim JC, et al. Patient-reported goal achievement after antimuscarinic treatment in patients with overactive bladder symptoms. Int J Clin Pract. 2012 Jul;66(7):663–70. doi: 10.1111/j.1742-1241.2012.02951.x. PMID: 22698418. [PubMed: 22698418] [CrossRef]

Cardozo L, Hall T, Ryan J, et al. Safety and efficacy of flexible-dose fesoterodine in British subjects with overactive bladder: insights into factors associated with dose escalation. Int Urogynecol J. 2012 Nov;23(11):1581–90. doi: 10.1007/s00192-012-1804-1. PMID: 22576329. [PubMed: 22576329] [CrossRef]

Cartwright R, Srikrishna S, Cardozo L, et al. Validity and reliability of patient selected goals as an outcome measure in overactive bladder. Int Urogynecol J. 2011 Jul;22(7):841–7. doi: 10.1007/s00192-011-1360-0. PMID: 21279328. [PubMed: 21279328] [CrossRef]

Ahlstrom K, Sandahl B, Sjoberg B, et al. Effect of combined treatment with phenylpropanolamine and estriol, compared with estriol treatment alone, in postmenopausal women with stress urinary incontinence. Gynecol Obstet Invest. 1990;30(1):37–43. PMID: 2227611. [PubMed: 2227611]

Aksac B, Aki S, Karan A, et al. Biofeedback and pelvic floor exercises for the rehabilitation of urinary stress incontinence. Gynecol Obstet Invest. 2003;56(1):23–7. . PMID: 12867764. [PubMed: 12867764]

Amundsen CL, Richter HE, Menefee SA, et al. OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial. Jama. 2016 Oct 04;316(13):1366–74. doi: 10.1001/jama.2016.14617. PMID: 27701661. [PMC free article: PMC5399419] [PubMed: 27701661] [CrossRef]

Bo K, Talseth T, Holme I. Single blind, randomised controlled trial of pelvic floor exercises, electrical stimulation, vaginal cones, and no treatment in management of genuine stress incontinence in women. Bmj. 1999 Feb 20;318(7182):487–93. PMID: 10024253. [PMC free article: PMC27740] [PubMed: 10024253]

Borello-France D, Burgio KL, Goode PS, et al. Adherence to behavioral interventions for urge incontinence when combined with drug therapy: adherence rates, barriers, and predictors. Phys Ther. 2010 Oct;90(10):1493–505. doi: 10.2522/ptj.20080387. PMID: 20671098. [PMC free article: PMC2949583] [PubMed: 20671098] [CrossRef]

Burgio KL, Locher JL, Goode PS, et al. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial. Jama. 1998 Dec 16;280(23):1995–2000. PMID: 9863850. [PubMed: 9863850]

Burns PA, Pranikoff K, Nochajski TH, et al. A comparison of effectiveness of biofeedback and pelvic muscle exercise treatment of stress incontinence in older community-dwelling women. J Gerontol. 1993 Jul;48(4):M167–74. PMID: 8315230. [PubMed: 8315230]

Anderson RU, MacDiarmid S, Kell S, et al. Effectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct. 2006 Sep;17(5):502–11. doi: 10.1007/s00192-005-0057-7. PMID: 16724169. [PubMed: 16724169] [CrossRef]

Castro RA, Arruda RM, Zanetti MR, et al. Single-blind, randomized, controlled trial of pelvic floor muscle training, electrical stimulation, vaginal cones, and no active treatment in the management of stress urinary incontinence. Clinics (Sao Paulo). 2008 Aug;63(4):465–72. PMID: 18719756. [PMC free article: PMC2664121] [PubMed: 18719756]

Fantl JA, Wyman JF, McClish DK, et al. Efficacy of bladder training in older women with urinary incontinence. Jama. 1991 Feb 06;265(5):609–13. PMID: 1987410. [PubMed: 1987410]

Fujishiro T, Enomoto H, Ugawa Y, et al. Magnetic stimulation of the sacral roots for the treatment of stress incontinence: an investigational study and placebo controlled trial. J Urol. 2000 Oct;164(4):1277–9. PMID: 10992380. [PubMed: 10992380]

Ghoniem G, Corcos J, Comiter C, et al. Cross-linked polydimethylsiloxane injection for female stress urinary incontinence: results of a multicenter, randomized, controlled, single-blind study. J Urol. 2009 Jan;181(1):204–10. doi: 10.1016/j.juro.2008.09.032. PMID: 19013613. [PubMed: 19013613] [CrossRef]

Gittelman M, Weiss H, Seidman L. A phase 2, randomized, double-blind, efficacy and safety study of oxybutynin vaginal ring for alleviation of overactive bladder symptoms in women. J Urol. 2014 Apr;191(4):1014–21. doi: 10.1016/j.juro.2013.11.019. PMID: 24231837. [PubMed: 24231837] [CrossRef]

Goode PS. Behavioral and drug therapy for urinary incontinence. Urology. 2004 Mar;63(3 Suppl 1):58–64. doi: 10.1016/j.urology.2003.10.032. PMID: 15013654. [PubMed: 15013654] [CrossRef]

Hahn I, Sommar S, Fall M. A comparative study of pelvic floor training and electrical stimulation for the treatment of genuine female stress urinary incontinence. Neurourology and Urodynamics. 1991;10(6):545–54.

Holtedahl K, Verelst M, Schiefloe A. A population based, randomized, controlled trial of conservative treatment for urinary incontinence in women. Acta Obstet Gynecol Scand. 1998 Jul;77(6):671–7. PMID: 9688247. [PubMed: 9688247]

Hung HC, Hsiao SM, Chih SY, et al. An alternative intervention for urinary incontinence: retraining diaphragmatic, deep abdominal and pelvic floor muscle coordinated function. Man Ther. 2010 Jun;15(3):273–9. doi: 10.1016/j.math.2010.01.008. PMID: 20185357. [PubMed: 20185357] [CrossRef]

Ishiko O, Hirai K, Sumi T, et al. Hormone replacement therapy plus pelvic floor muscle exercise for postmenopausal stress incontinence. A randomized, controlled trial. J Reprod Med. 2001 Mar;46(3):213–20. PMID: 11304861. [PubMed: 11304861]

Jabs C, Carleton E. Efficacy of botulinum toxin a intradetrusor injections for non-neurogenic urinary urge incontinence: a randomized double-blind controlled trial. J Obstet Gynaecol Can. 2013 Jan;35(1):53–60. PMID: 23343798. [PubMed: 23343798]

Kafri R, Deutscher D, Shames J, et al. Randomized trial of a comparison of rehabilitation or drug therapy for urgency urinary incontinence: 1-year follow-up. Int Urogynecol J. 2013 Jul;24(7):1181–9. doi: 10.1007/s00192-012-1992-8. PMID: 23160873. [PubMed: 23160873] [CrossRef]

Kim JI. Continence efficacy intervention program for community residing women with stress urinary incontinence in Japan. Public Health Nurs. 2001 Jan-Feb;18(1):64–72. PMID: 11251875. [PubMed: 11251875]

Lagro-Janssen AL, Debruyne FM, Smits AJ, et al. The effects of treatment of urinary incontinence in general practice. Fam Pract. 1992 Sep;9(3):284–9. PMID: 1459383. [PubMed: 1459383]

Lagro-Janssen TL, Debruyne FM, Smits AJ, et al. Controlled trial of pelvic floor exercises in the treatment of urinary stress incontinence in general practice. Br J Gen Pract. 1991 Nov;41(352):445–9. PMID: 1807303. [PMC free article: PMC1371786] [PubMed: 1807303]

Lee PE, Kung RC, Drutz HP. Periurethral autologous fat injection as treatment for female stress urinary incontinence: a randomized double-blind controlled trial. J Urol. 2001 Jan;165(1):153–8. doi: 10.1097/00005392-200101000-00037. PMID: 11125386. [PubMed: 11125386] [CrossRef]

Carrion Perez F, Rodriguez Moreno MS, Carnerero Cordoba L, et al. [Telerehabilitation to treat stress urinary incontinence. Pilot study]. Med Clin (Barc). 2015 May 21;144(10):445–8. doi: 10.1016/j.medcli.2014.05.036. PMID: 25087210. [PubMed: 25087210] [CrossRef]

Bertotto A, Schvartzman R, Uchoa S, et al. Effect of electromyographic biofeedback as an add-on to pelvic floor muscle exercises on neuromuscular outcomes and quality of life in postmenopausal women with stress urinary incontinence: A randomized controlled trial. Neurourol Urodyn. 2017 Nov;36(8):2142–7. doi: 10.1002/nau.23258. PMID: 28508398. [PubMed: 28508398] [CrossRef]

Aukee P, Immonen P, Penttinen J, et al. Increase in pelvic floor muscle activity after 12 weeks’ training: a randomized prospective pilot study. Urology. 2002 Dec;60(6):1020–3; discussion 3–4. PMID: 12475661. [PubMed: 12475661]

Lovatsis D, Best C, Diamond P. Short-term Uresta efficacy (SURE) study: a randomized controlled trial of the Uresta continence device. Int Urogynecol J. 2017 Jan;28(1):147–50. doi: 10.1007/s00192-016-3090-9. PMID: 27438055. [PubMed: 27438055] [CrossRef]

Luber KM, Wolde-Tsadik G. Efficacy of functional electrical stimulation in treating genuine stress incontinence: a randomized clinical trial. Neurourol Urodyn. 1997;16(6):543–51. PMID: 9353803. [PubMed: 9353803]

McFall SL, Yerkes AM, Cowan LD. Outcomes of a small group educational intervention for urinary incontinence: episodes of incontinence and other urinary symptoms. J Aging Health. 2000 May;12(2):250–67. doi: 10.1177/089826430001200206. PMID: 11010699. [PubMed: 11010699] [CrossRef]

Millard RJ, Moore K, Rencken R, et al. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial. BJU Int. 2004 Feb;93(3):311–8. PMID: 14764128. [PubMed: 14764128]

Moore KH, Hay DM, Imrie AE, et al. Oxybutynin hydrochloride (3 mg) in the treatment of women with idiopathic detrusor instability. Br J Urol. 1990 Nov;66(5):479–85. PMID: 2249115. [PubMed: 2249115]

Norton PA, Zinner NR, Yalcin I, et al. Duloxetine versus placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol. 2002 Jul;187(1):40–8. PMID: 12114886. [PubMed: 12114886]

Peters KM, Macdiarmid SA, Wooldridge LS, et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol. 2009 Sep;182(3):1055–61. doi: 10.1016/j.juro.2009.05.045. PMID: 19616802. [PubMed: 19616802] [CrossRef]

Rogers R, Bachmann G, Jumadilova Z, et al. Efficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active women. Int Urogynecol J Pelvic Floor Dysfunct. 2008 Nov;19(11):1551–7. doi: 10.1007/s00192-008-0688-6. PMID: 18685795. [PubMed: 18685795] [CrossRef]

Rovner E, Kennelly M, Schulte-Baukloh H, et al. Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder. Neurourol Urodyn. 2011 Apr;30(4):556–62. doi: 10.1002/nau.21021. PMID: 21351127. [PubMed: 21351127] [CrossRef]

Rovner ES, Dmochowski RR, Leach GE, et al. A randomized, controlled clinical trial of a novel intravesical pressure attenuation device for the treatment of stress urinary incontinence. J Urol. 2013 Dec;190(6):2243–50. doi: 10.1016/j.juro.2013.06.042. PMID: 23796570. [PubMed: 23796570] [CrossRef]

Engberg S, Cohen S, Sereika SM. The efficacy of acupuncture in treating urge and mixed incontinence in women: a pilot study. J Wound Ostomy Continence Nurs. 2009 Nov-Dec;36(6):661–70. doi: 10.1097/WON.0b013e3181bd82dd. PMID: 19920749. [PubMed: 19920749] [CrossRef]

Sand PK, Richardson DA, Staskin DR, et al. Pelvic floor electrical stimulation in the treatment of genuine stress incontinence: a multicenter, placebo-controlled trial. Am J Obstet Gynecol. 1995 Jul;173(1):72–9. PMID: 7631730. [PubMed: 7631730]

Schreiner L, dos Santos TG, Knorst MR, et al. Randomized trial of transcutaneous tibial nerve stimulation to treat urge urinary incontinence in older women. Int Urogynecol J. 2010 Sep;21(9):1065–70. doi: 10.1007/s00192-010-1165-6. PMID: 20458465. [PubMed: 20458465] [CrossRef]

Smith JJ, 3rd. Intravaginal stimulation randomized trial. J Urol. 1996 Jan;155(1):127–30. PMID: 7490809. [PubMed: 7490809]

Szonyi G, Collas DM, Ding YY, et al. Oxybutynin with bladder retraining for detrusor instability in elderly people: a randomized controlled trial. Age Ageing. 1995 Jul;24(4):287–91. PMID: 7484484. [PubMed: 7484484]

Terlikowski R, Dobrzycka B, Kinalski M, et al. Transvaginal electrical stimulation with surface-EMG biofeedback in managing stress urinary incontinence in women of premenopausal age: a double-blind, placebo-controlled, randomized clinical trial. Int Urogynecol J. 2013 Oct;24(10):1631–8. doi: 10.1007/s00192-013-2071-5. PMID: 23443345. [PMC free article: PMC3779318] [PubMed: 23443345] [CrossRef]

Visco AG, Brubaker L, Richter HE, et al. Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. N Engl J Med. 2012 Nov 08;367(19):1803–13. doi: 10.1056/NEJMoa1208872. PMID: 23036134. [PMC free article: PMC3543828] [PubMed: 23036134] [CrossRef]

Wang AC, Wang YY, Chen MC. Single-blind, randomized trial of pelvic floor muscle training, biofeedback-assisted pelvic floor muscle training, and electrical stimulation in the management of overactive bladder. Urology. 2004 Jan;63(1):61–6. PMID: 14751349. [PubMed: 14751349]

Sun Z, Zhu L, Lang J, et al. [Continuous improvement of portable domestic pelvic floor neuromuscular electrical stimulation on the pelvic floor function of patients with urinary incontinence]. Zhonghua Fu Chan Ke Za Zhi. 2015 Dec;50(12):937–41. PMID: 26887879. [PubMed: 26887879]

Wells TJ, Brink CA, Diokno AC, et al. Pelvic muscle exercise for stress urinary incontinence in elderly women. J Am Geriatr Soc. 1991 Aug;39(8):785–91. PMID: 2071809. [PubMed: 2071809]

Williams KS, Assassa RP, Gillies CL, et al. A randomized controlled trial of the effectiveness of pelvic floor therapies for urodynamic stress and mixed incontinence. BJU Int. 2006 Nov;98(5):1043–50. doi: 10.1111/j.1464-410X.2006.06484.x. PMID: 17034605. [PubMed: 17034605] [CrossRef]

Amaro JL, Gameiro MO, Kawano PR, et al. Intravaginal electrical stimulation: a randomized, double-blind study on the treatment of mixed urinary incontinence. Acta Obstet Gynecol Scand. 2006;85(5):619–22. doi: 10.1080/00016340500495058. PMID: 16752244. [PubMed: 16752244] [CrossRef]

Bent AE, Gousse AE, Hendrix SL, et al. Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence. Neurourol Urodyn. 2008;27(3):212–21. doi: 10.1002/nau.20471. PMID: 17580357. [PubMed: 17580357] [CrossRef]

Brubaker L, Benson JT, Bent A, et al. Transvaginal electrical stimulation for female urinary incontinence. Am J Obstet Gynecol. 1997 Sep;177(3):536–40. PMID: 9322620. [PubMed: 9322620]

Brubaker L, Richter HE, Visco A, et al. Refractory idiopathic urge urinary incontinence and botulinum A injection. J Urol. 2008 Jul;180(1):217–22. doi: 10.1016/j.juro.2008.03.028. PMID: 18499184. [PMC free article: PMC2597793] [PubMed: 18499184] [CrossRef]

Burgio KL, Goode PS, Richter HE, et al. Combined behavioral and individualized drug therapy versus individualized drug therapy alone for urge urinary incontinence in women. J Urol. 2010 Aug;184(2):598–603. doi: 10.1016/j.juro.2010.03.141. PMID: 20639023. [PubMed: 20639023] [CrossRef]

But I. Conservative treatment of female urinary incontinence with functional magnetic stimulation. Urology. 2003 Mar;61(3):558–61. PMID: 12639647. [PubMed: 12639647]

But I, Faganelj M, Sostaric A. Functional magnetic stimulation for mixed urinary incontinence. J Urol. 2005 May;173(5):1644–6. doi: 10.1097/01.ju.0000157336.87781.32. PMID: 15821527. [PubMed: 15821527] [CrossRef]

Capobianco G, Donolo E, Borghero G, et al. Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women. Arch Gynecol Obstet. 2012 Feb;285(2):397–403. doi: 10.1007/s00404-011-1955-1. PMID: 21706345. [PubMed: 21706345] [CrossRef]

Cardozo L, Drutz HP, Baygani SK, et al. Pharmacological treatment of women awaiting surgery for stress urinary incontinence. Obstet Gynecol. 2004 Sep;104(3):511–9. doi: 10.1097/01.AOG.0000134525.86480.0f. PMID: 15339761. [PubMed: 15339761] [CrossRef]

Cardozo L, Lange R, Voss S, et al. Short- and long-term efficacy and safety of duloxetine in women with predominant stress urinary incontinence. Curr Med Res Opin. 2010 Feb;26(2):253–61. doi: 10.1185/03007990903438295. PMID: 19929591. [PubMed: 19929591] [CrossRef]

Diokno AC, Sampselle CM, Herzog AR, et al. Prevention of urinary incontinence by behavioral modification program: a randomized, controlled trial among older women in the community. J Urol. 2004 Mar;171(3):1165–71. doi: 10.1097/01.ju.0000111503.73803.c2. PMID: 14767293. [PubMed: 14767293] [CrossRef]

Goode PS, Burgio KL, Locher JL, et al. Effect of behavioral training with or without pelvic floor electrical stimulation on stress incontinence in women: a randomized controlled trial. Jama. 2003 Jul 16;290(3):345–52. doi: 10.1001/jama.290.3.345. PMID: 12865375. [PubMed: 12865375] [CrossRef]

Jackson S, Shepherd A, Brookes S, et al. The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: a double-blind placebo-controlled trial. Br J Obstet Gynaecol. 1999 Jul;106(7):711–8. PMID: 10428529. [PubMed: 10428529]

DuBeau CE, Khullar V, Versi E. “Unblinding” in randomized controlled drug trials for urinary incontinence: Implications for assessing outcomes when adverse effects are evident. Neurourol Urodyn. 2005;24(1):13–20. doi: 10.1002/nau.20083. PMID: 15570576. [PubMed: 15570576] [CrossRef]

Kinchen KS, Obenchain R, Swindle R. Impact of duloxetine on quality of life for women with symptoms of urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2005 Sep-Oct;16(5):337–44. doi: 10.1007/s00192-004-1270-5. PMID: 15662490. [PubMed: 15662490] [CrossRef]

Lian A, Zhang W, Wang S. [Mild and moderate female stress urinary incontinence treated with transcutaneous acupoint electrical stimulation: a randomized controlled trial]. Zhongguo Zhen Jiu. 2015 Apr;35(4):327–9. PMID: 26054138. [PubMed: 26054138]

Lin AT, Sun MJ, Tai HL, et al. Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial. BMC Urol. 2008 Jan 25;8:2. doi: 10.1186/1471-2490-8-2. PMID: 18221532. [PMC free article: PMC2266773] [PubMed: 18221532] [CrossRef]

Liu Z, Liu Y, Xu H, et al. Effect of Electroacupuncture on Urinary Leakage Among Women With Stress Urinary Incontinence: A Randomized Clinical Trial. Jama. 2017 Jun 27;317(24):2493–501. doi: 10.1001/jama.2017.7220. PMID: 28655016. [PMC free article: PMC5815072] [PubMed: 28655016] [CrossRef]

Lopes P, Rimbault F, Scheffler M, et al. [Multicentric prospective randomized and controlled study assessing effectiveness of intravaginal electrostimulation at home compared to usual care in female patients with urinary incontinence and prior perineal reeducation]. Gynecol Obstet Fertil. 2014 Nov;42(11):779–86. doi: 10.1016/j.gyobfe.2014.09.009. PMID: 25444700. [PubMed: 25444700] [CrossRef]

McMichael. Safety and Efficacy Study of a New Treatment for Symptoms of Urinary Incontinence. 2013. https:​//clinicaltrials​.gov/ct2/show/NCT01340066. Accessed on October 7, 2017.

Oldham J, Herbert J, McBride K. Evaluation of a new disposable “tampon like” electrostimulation technology (Pelviva(R)) for the treatment of urinary incontinence in women: a 12-week single blind randomized controlled trial. Neurourol Urodyn. 2013 Jun;32(5):460–6. doi: 10.1002/nau.22326. PMID: 23023996. [PubMed: 23023996] [CrossRef]

But I, Goldstajn MS, Oreskovic S. Comparison of two selective muscarinic receptor antagonists (solifenacin and darifenacin) in women with overactive bladder-the SOLIDAR study. Coll Antropol. 2012 Dec;36(4):1347–53. PMID: 23390832. [PubMed: 23390832]

Rutledge TL, Rogers R, Lee SJ, et al. A pilot randomized control trial to evaluate pelvic floor muscle training for urinary incontinence among gynecologic cancer survivors. Gynecol Oncol. 2014 Jan;132(1):154–8. doi: 10.1016/j.ygyno.2013.10.024. PMID: 24183730. [PMC free article: PMC5399541] [PubMed: 24183730] [CrossRef]

Samuelsson E. Treatment of Stress Urinary Incontinence Via Smartphone. 2017. https:​//clinicaltrials​.gov/ct2/show/NCT01848938. Accessed on October 5, 2017.

Schagen van Leeuwen JH, Lange RR, Jonasson AF, et al. Efficacy and safety of duloxetine in elderly women with stress urinary incontinence or stress-predominant mixed urinary incontinence. Maturitas. 2008 Jun 20;60(2):138–47. doi: 10.1016/j.maturitas.2008.04.012. PMID: 18547757. [PubMed: 18547757] [CrossRef]

Spruijt J, Vierhout M, Verstraeten R, et al. Vaginal electrical stimulation of the pelvic floor: a randomized feasibility study in urinary incontinent elderly women. Acta Obstet Gynecol Scand. 2003 Nov;82(11):1043–8. PMID: 14616279. [PubMed: 14616279]

Steers WD, Herschorn S, Kreder KJ, et al. Duloxetine compared with placebo for treating women with symptoms of overactive bladder. BJU Int. 2007 Aug;100(2):337–45. doi: 10.1111/j.1464-410X.2007.06980.x. PMID: 17511767. [PubMed: 17511767] [CrossRef]

Subak LL, Quesenberry CP, Posner SF, et al. The effect of behavioral therapy on urinary incontinence: a randomized controlled trial. Obstet Gynecol. 2002 Jul;100(1):72–8. PMID: 12100806. [PubMed: 12100806]

Talley KMC, Wyman JF, Bronas U, et al. Defeating Urinary Incontinence with Exercise Training: Results of a Pilot Study in Frail Older Women. J Am Geriatr Soc. 2017 Jun;65(6):1321–7. doi: 10.1111/jgs.14798. PMID: 28248418. [PMC free article: PMC5478439] [PubMed: 28248418] [CrossRef]

Tannenbaum C, Agnew R, Benedetti A, et al. Effectiveness of continence promotion for older women via community organisations: a cluster randomised trial. BMJ Open. 2013 Dec 10;3(12):e004135. doi: 10.1136/bmjopen-2013-004135. PMID: 24334159. [PMC free article: PMC3863125] [PubMed: 24334159] [CrossRef]

Thuroff JW, Bunke B, Ebner A, et al. Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo. J Urol. 1991 Apr;145(4):813–6; discussion 6–7. PMID: 2005707. [PubMed: 2005707]

van Kerrebroeck P, Abrams P, Lange R, et al. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence. Bjog. 2004 Mar;111(3):249–57. PMID: 14961887. [PubMed: 14961887]

Waetjen LE, Brown JS, Modelska K, et al. Effect of raloxifene on urinary incontinence: a randomized controlled trial. Obstet Gynecol. 2004 Feb;103(2):261–6. doi: 10.1097/01.AOG.0000109429.67671.d1. PMID: 14754693. [PubMed: 14754693] [CrossRef]

Wang S, Lv J, Feng X, et al. Efficacy of Electrical Pudendal Nerve Stimulation in Treating Female Stress Incontinence. Urology. 2016 May;91:64–9. doi: 10.1016/j.urology.2016.02.027. PMID: 26921645. [PubMed: 26921645] [CrossRef]

Wiegersma M, Panman CM, Kollen BJ, et al. Effect of pelvic floor muscle training compared with watchful waiting in older women with symptomatic mild pelvic organ prolapse: randomised controlled trial in primary care. Bmj. 2014 Dec 22;349:g7378. doi: 10.1136/bmj.g7378. PMID: 25533442. [PMC free article: PMC4273538] [PubMed: 25533442] [CrossRef]

Yalcin I, Patrick DL, Summers K, et al. Minimal clinically important differences in Incontinence Quality-of-Life scores in stress urinary incontinence. Urology. 2006 Jun;67(6):1304–8. doi: 10.1016/j.urology.2005.12.006. PMID: 16750246. [PubMed: 16750246] [CrossRef]

Steinauer JE, Waetjen LE, Vittinghoff E, et al. Postmenopausal hormone therapy: does it cause incontinence? Obstet Gynecol. 2005 Nov;106(5 Pt 1):940–5. doi: 10.1097/01.aog.0000180394.08406.15. PMID: 16260510. [PMC free article: PMC1557396] [PubMed: 16260510] [CrossRef]

Khullar V, Hill S, Laval KU, et al. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial. Urology. 2004 Aug;64(2):269–74; discussion 74–5. doi: 10.1016/j.urology.2004.02.029. PMID: 15302476. [PubMed: 15302476] [CrossRef]

Furst MC, Mendonca RR, Rodrigues AO, et al. Long-term results of a clinical trial comparing isolated vaginal stimulation with combined treatment for women with stress incontinence. Einstein (Sao Paulo). 2014 Apr;12(2):168–74. PMID: 25003921. [PMC free article: PMC4891158] [PubMed: 25003921]

Rogers RG, Bachmann G, Scarpero H, et al. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence. Curr Med Res Opin. 2009 Sep;25(9):2159–65. doi: 10.1185/03007990903103279. PMID: 19601704. [PubMed: 19601704] [CrossRef]

Baker J, Costa D, Guarino JM, et al. Comparison of mindfulness-based stress reduction versus yoga on urinary urge incontinence: a randomized pilot study. with 6-month and 1-year follow-up visits. Female Pelvic Med Reconstr Surg. 2014 May-Jun;20(3):141–6. doi: 10.1097/spv.0000000000000061. PMID: 24763155. [PubMed: 24763155] [CrossRef]

Borello-France DF, Zyczynski HM, Downey PA, et al. Effect of pelvic-floor muscle exercise position on continence and quality-of-life outcomes in women with stress urinary incontinence. Phys Ther. 2006 Jul;86(7):974–86. PMID: 16813477. [PubMed: 16813477]

Burgio KL, Goode PS, Locher JL, et al. Behavioral training with and without biofeedback in the treatment of urge incontinence in older women: a randomized controlled trial. Jama. 2002 Nov 13;288(18):2293–9. PMID: 12425706. [PubMed: 12425706]

Cammu H, Van Nylen M. Pelvic floor exercises versus vaginal weight cones in genuine stress incontinence. Eur J Obstet Gynecol Reprod Biol. 1998 Mar;77(1):89–93. PMID: 9550207. [PubMed: 9550207]

Carmona MVO, Molleja ÁMG, Ríos IL, et al. Neuroestimulación percutánea del nervio tibial posterior frente a neuroestimulación de B 6 (Sanyinjiao) en incontinencia urinaria de urgencia. Revista Internacional de Acupuntura. 2013;7(4):124–30.

Cornu JN, Mouly S, Amarenco G, et al. 75NC007 device for noninvasive stress urinary incontinence management in women: a randomized controlled trial. Int Urogynecol J. 2012 Dec;23(12):1727–34. doi: 10.1007/s00192-012-1814-z. PMID: 22588140. [PubMed: 22588140] [CrossRef]

Correia GN, Pereira VS, Hirakawa HS, et al. Effects of surface and intravaginal electrical stimulation in the treatment of women with stress urinary incontinence: randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2014 Feb;173:113–8. doi: 10.1016/j.ejogrb.2013.11.023. PMID: 24382548. [PubMed: 24382548] [CrossRef]

de Oliveira Camargo F, Rodrigues AM, Arruda RM, et al. Pelvic floor muscle training in female stress urinary incontinence: comparison between group training and individual treatment using PERFECT assessment scheme. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Dec;20(12):1455–62. doi: 10.1007/s00192-009-0971-1. PMID: 19690792. [PubMed: 19690792] [CrossRef]

de Souza Abreu N, de Castro Villas Boas B, Netto JM, et al. Dynamic lumbopelvic stabilization for treatment of stress urinary incontinence in women: Controlled and randomized clinical trial. Neurourol Urodyn. 2017 Mar 27 doi: 10.1002/nau.23261. PMID: 28346721. [PubMed: 28346721] [CrossRef]

Delgado D, White P, Trochez R, et al. A pilot randomised controlled trial of the pelvic toner device in female stress urinary incontinence. Int Urogynecol J. 2013 Oct;24(10):1739–45. doi: 10.1007/s00192-013-2107-x. PMID: 23640005. [PubMed: 23640005] [CrossRef]

Du Moulin MF, Hamers JP, Paulus A, et al. Effects of introducing a specialized nurse in the care of community-dwelling women suffering from urinary incontinence: a randomized controlled trial. J Wound Ostomy Continence Nurs. 2007 Nov-Dec;34(6):631–40. doi: 10.1097/01.won.0000299814.98230.13. PMID: 18030102. [PubMed: 18030102] [CrossRef]

Ferreira M, Santos PC. Impact of exercise programs in woman’s quality of life with stress urinary incontinence. Revista Portuguesa de Saúde Pública. 2012;30:3–10.

Fitz FF, Resende AP, Stupp L, et al. [Effect the adding of biofeedback to the training of the pelvic floor muscles to treatment of stress urinary incontinence]. Rev Bras Ginecol Obstet. 2012 Nov;34(11):505–10. PMID: 23288261. [PubMed: 23288261]

Fitz FF, Stupp L, da Costa TF, et al. Outpatient biofeedback in addition to home pelvic floor muscle training for stress urinary incontinence: a randomized controlled trial. Neurourol Urodyn. 2017 Feb 07 doi: 10.1002/nau.23226. PMID: 28169458. [PubMed: 28169458] [CrossRef]

Galea MP, Tisseverasinghe S, Sherburn M. A randomised controlled trial of transabdominal ultrasound biofeedback for pelvic floor muscle training in older women with urinary incontinence. Australian and New Zealand Continence Journal, The. 2013;19(2):38.

Ghaderi F, Mohammadi K, Amir Sasan R, et al. Effects of Stabilization Exercises Focusing on Pelvic Floor Muscles on Low Back Pain and Urinary Incontinence in Women. Urology. 2016 Jul;93:50–4. doi: 10.1016/j.urology.2016.03.034. PMID: 27059833. [PubMed: 27059833] [CrossRef]

Golmakani N, Khadem N, Arabipoor A, et al. Behavioral Intervention Program versus Vaginal Cones on Stress Urinary Incontinence and Related Quality of Life: A Randomized Clinical Trial. Oman Med J. 2014 Jan;29(1):32–8. doi: 10.5001/omj.2014.08. PMID: 24498480. [PMC free article: PMC3910410] [PubMed: 24498480] [CrossRef]

Gozukara YM, Akalan G, Tok EC, et al. The improvement in pelvic floor symptoms with weight loss in obese women does not correlate with the changes in pelvic anatomy. Int Urogynecol J. 2014 Sep;25(9):1219–25. doi: 10.1007/s00192-014-2368-z. PMID: 24711149. [PubMed: 24711149] [CrossRef]

Hirakawa T, Suzuki S, Kato K, et al. Randomized controlled trial of pelvic floor muscle training with or without biofeedback for urinary incontinence. Int Urogynecol J. 2013 Aug;24(8):1347–54. doi: 10.1007/s00192-012-2012-8. PMID: 23306768. [PubMed: 23306768] [CrossRef]

Huang AJ, Jenny HE, Chesney MA, et al. A group-based yoga therapy intervention for urinary incontinence in women: a pilot randomized trial. Female Pelvic Med Reconstr Surg. 2014 May-Jun;20(3):147–54. doi: 10.1097/spv.0000000000000072. PMID: 24763156. [PMC free article: PMC4310548] [PubMed: 24763156] [CrossRef]

Huang AJ, Stewart AL, Hernandez AL, et al. Sexual function among overweight and obese women with urinary incontinence in a randomized controlled trial of an intensive behavioral weight loss intervention. J Urol. 2009 May;181(5):2235–42. doi: 10.1016/j.juro.2009.01.046. PMID: 19296980. [PMC free article: PMC2744348] [PubMed: 19296980] [CrossRef]

Huebner M, Riegel K, Hinninghofen H, et al. Pelvic floor muscle training for stress urinary incontinence: a randomized, controlled trial comparing different conservative therapies. Physiother Res Int. 2011 Sep;16(3):133–40. doi: 10.1002/pri.489. PMID: 20848671. [PubMed: 20848671] [CrossRef]

Jeyaseelan SM, Haslam EJ, Winstanley J, et al. An evaluation of a new pattern of electrical stimulation as a treatment for urinary stress incontinence: a randomized, double-blind, controlled trial. Clin Rehabil. 2000 Dec;14(6):631–40. doi: 10.1191/0269215500cr372oa. PMID: 11128739. [PubMed: 11128739] [CrossRef]

Jha S, Walters SJ, Bortolami O, et al. Impact of pelvic floor muscle training on sexual function of women with urinary incontinence and a comparison of electrical stimulation versus standard treatment (IPSU trial): a randomised controlled trial. Physiotherapy. 2017 Jun 23 doi: 10.1016/j.physio.2017.06.003. PMID: 28801034. [PubMed: 28801034] [CrossRef]

Jordre B, Schweinle W. Comparing resisted hip rotation with pelvic floor muscle training in women with stress urinary incontinence: a pilot study. Journal of Women’s Health Physical Therapy. 2014;38(2):81–9.

Kaya S, Akbayrak T, Gursen C, et al. Short-term effect of adding pelvic floor muscle training to bladder training for female urinary incontinence: a randomized controlled trial. Int Urogynecol J. 2015 Feb;26(2):285–93. doi: 10.1007/s00192-014-2517-4. PMID: 25266357. [PubMed: 25266357] [CrossRef]

Kim EY, Kim SY, Oh DW. Pelvic floor muscle exercises utilizing trunk stabilization for treating postpartum urinary incontinence: randomized controlled pilot trial of supervised versus unsupervised training. Clin Rehabil. 2012 Feb;26(2):132–41. doi: 10.1177/0269215511411498. PMID: 21849373. [PubMed: 21849373] [CrossRef]

Kumari S, Jain V, Mandal AK, et al. Behavioral therapy for urinary incontinence in India. Int J Gynaecol Obstet. 2008 Nov;103(2):125–30. doi: 10.1016/j.ijgo.2008.06.019. PMID: 18755458. [PubMed: 18755458] [CrossRef]

Lamb SE, Pepper J, Lall R, et al. Group treatments for sensitive health care problems: a randomised controlled trial of group versus individual physiotherapy sessions for female urinary incontinence. BMC Womens Health. 2009 Sep 14;9:26. doi: 10.1186/1472-6874-9-26. PMID: 19751517. [PMC free article: PMC2754423] [PubMed: 19751517] [CrossRef]

Leong BS, Mok NW. Effectiveness of a new standardised Urinary Continence Physiotherapy Programme for community-dwelling older women in Hong Kong. Hong Kong Med J. 2015 Feb;21(1):30–7. doi: 10.12809/hkmj134185. PMID: 25377297. [PubMed: 25377297] [CrossRef]

Liebergall-Wischnitzer M, Hochner-Celnikier D, Lavy Y, et al. Paula method of circular muscle exercises for urinary stress incontinence-a clinical trial. Int Urogynecol J Pelvic Floor Dysfunct. 2005 Sep-Oct;16(5):345–51. doi: 10.1007/s00192-004-1261-6. PMID: 15660184. [PubMed: 15660184] [CrossRef]

Liebergall-Wischnitzer M, Hochner-Celnikier D, Lavy Y, et al. Randomized trial of circular muscle versus pelvic floor training for stress urinary incontinence in women. J Womens Health (Larchmt). 2009 Mar;18(3):377–85. doi: 10.1089/jwh.2008.0950. PMID: 19281321. [PubMed: 19281321] [CrossRef]

Lim R, Liong ML, Leong WS, et al. Pulsed Magnetic Stimulation for Stress Urinary Incontinence: 1-Year Followup Results. J Urol. 2017 May;197(5):1302–8. doi: 10.1016/j.juro.2016.11.091. PMID: 27871927. [PubMed: 27871927] [CrossRef]

Manganotti P, Zaina F, Vedovi E, et al. Repetitive magnetic stimulation of the sacral roots for the treatment of stress incontinence: a brief report. Eura Medicophys. 2007 Sep;43(3):339–44. PMID: 17259914. [PubMed: 17259914]

Manonai J, Kamthaworn S, Petsarb K, et al. Development of a pelvic floor muscle strength evaluation device. J Med Assoc Thai. 2015 Mar;98(3):219–25. PMID: 25920290. [PubMed: 25920290]

McLean L, Varette K, Gentilcore-Saulnier E, et al. Pelvic floor muscle training in women with stress urinary incontinence causes hypertrophy of the urethral sphincters and reduces bladder neck mobility during coughing. Neurourol Urodyn. 2013 Nov;32(8):1096–102. doi: 10.1002/nau.22343. PMID: 23861324. [PMC free article: PMC4894819] [PubMed: 23861324] [CrossRef]

Moore KH, O’Sullivan RJ, Simons A, et al. Randomised controlled trial of nurse continence advisor therapy compared with standard urogynaecology regimen for conservative incontinence treatment: efficacy, costs and two year follow up. Bjog. 2003 Jul;110(7):649–57. PMID: 12842055. [PubMed: 12842055]

Ng SC, Lin TL, Chang SJ, et al. Nursing intervention to enhance efficacy of home practice of pelvic floor muscle exercises in treating mixed urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2008 May;19(5):637–42. doi: 10.1007/s00192-007-0492-8. PMID: 18004495. [PubMed: 18004495] [CrossRef]

Ozlu A, Yildiz N, Oztekin O. Comparison of the efficacy of perineal and intravaginal biofeedback assisted pelvic floor muscle exercises in women with urodynamic stress urinary incontinence. Neurourol Urodyn. 2017 Mar 27 doi: 10.1002/nau.23257. PMID: 28345778. [PubMed: 28345778] [CrossRef]

Pereira VS, Bonioti L, Correia GN, et al. [Effects of surface electrical stimulation in older women with stress urinary incontinence: a randomized controlled pilot study]. Actas Urol Esp. 2012 Sep;36(8):491–6. doi: 10.1016/j.acuro.2011.11.016. PMID: 22840592. [PubMed: 22840592] [CrossRef]

Pereira VS, Correia GN, Driusso P. Individual and group pelvic floor muscle training versus no treatment in female stress urinary incontinence: a randomized controlled pilot study. Eur J Obstet Gynecol Reprod Biol. 2011 Dec;159(2):465–71. doi: 10.1016/j.ejogrb.2011.09.003. PMID: 21962461. [PubMed: 21962461] [CrossRef]

Pereira VS, de Melo MV, Correia GN, et al. Long-term effects of pelvic floor muscle training with vaginal cone in post-menopausal women with urinary incontinence: a randomized controlled trial. Neurourol Urodyn. 2013 Jan;32(1):48–52. doi: 10.1002/nau.22271. PMID: 22674639. [PubMed: 22674639] [CrossRef]

Porta-Roda O, Vara-Paniagua J, Diaz-Lopez MA, et al. Effect of vaginal spheres and pelvic floor muscle training in women with urinary incontinence: a randomized, controlled trial. Neurourol Urodyn. 2015 Aug;34(6):533–8. doi: 10.1002/nau.22640. PMID: 25130167. [PubMed: 25130167] [CrossRef]

Price DM, Noblett K. Prospective Randomized Crossover Trial Comparing Continuous and Cyclic Stimulation in InterStim Therapy. Female Pelvic Med Reconstr Surg. 2015 Nov-Dec;21(6):355–8. doi: 10.1097/spv.0000000000000188. PMID: 26506165. [PubMed: 26506165] [CrossRef]

Seo JT, Yoon H, Kim YH. A randomized prospective study comparing new vaginal cone and FES-Biofeedback. Yonsei Med J. 2004 Oct 31;45(5):879–84. doi: 10.3349/ymj.2004.45.5.879. PMID: 15515199. [PubMed: 15515199] [CrossRef]

Solberg M, Alraek T, Mdala I, et al. A pilot study on the use of acupuncture or pelvic floor muscle training for mixed urinary incontinence. Acupunct Med. 2016 Feb;34(1):7–13. doi: 10.1136/acupmed-2015-010828. PMID: 26362793. [PMC free article: PMC4789711] [PubMed: 26362793] [CrossRef]

Sran M, Mercier J, Wilson P, et al. Physical therapy for urinary incontinence in postmenopausal women with osteoporosis or low bone density: a randomized controlled trial. Menopause. 2016 Mar;23(3):286–93. doi: 10.1097/gme.0000000000000594. PMID: 26886884. [PubMed: 26886884] [CrossRef]

Sung MS, Choi YH, Back SH, et al. The effect of pelvic floor muscle exercises on genuine stress incontinence among Korean women-focusing on its effects on the quality of life. Yonsei Med J. 2000 Apr;41(2):237–51. doi: 10.3349/ymj.2000.41.2.237. PMID: 10817026. [PubMed: 10817026] [CrossRef]

Tibaek S, Gard G, Jensen R. Is there a long-lasting effect of pelvic floor muscle training in women with urinary incontinence after ischemic stroke? A 6-month follow-up study. Int Urogynecol J Pelvic Floor Dysfunct. 2007 Mar;18(3):281–7. doi: 10.1007/s00192-006-0137-3. PMID: 16673051. [PubMed: 16673051] [CrossRef]

Tsai PY, Wang CP, Hsieh CY, et al. Long-term sacral magnetic stimulation for refractory stress urinary incontinence. Arch Phys Med Rehabil. 2014 Dec;95(12):2231–8. doi: 10.1016/j.apmr.2014.07.010. PMID: 25073008. [PubMed: 25073008] [CrossRef]

Wallis MC, Davies EA, Thalib L, et al. Pelvic static magnetic stimulation to control urinary incontinence in older women: a randomized controlled trial. Clin Med Res. 2012 Feb;10(1):7–14. doi: 10.3121/cmr.2011.1008. PMID: 21817123. [PMC free article: PMC3280454] [PubMed: 21817123] [CrossRef]

Wyman JF, Fantl JA, McClish DK, et al. Comparative efficacy of behavioral interventions in the management of female urinary incontinence. Continence Program for Women Research Group. Am J Obstet Gynecol. 1998 Oct;179(4):999–1007. PMID: 9790388. [PubMed: 9790388]

Wyman JF, Fantl JA, McClish DK, et al. Quality of life following bladder training in older women with urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 1997;8(4):223–9. PMID: 9449301. [PubMed: 9449301]

Xu H, Liu B, Wu J, et al. A Pilot Randomized Placebo Controlled Trial of Electroacupuncture for Women with Pure Stress Urinary Incontinence. PLoS One. 2016;11(3):e0150821. doi: 10.1371/journal.pone.0150821. PMID: 26960195. [PMC free article: PMC4784883] [PubMed: 26960195] [CrossRef]

Yamanishi T, Suzuki T, Sato R, et al. Effects of magnetic stimulation on urodynamic stress incontinence refractory to pelvic floor muscle training in a randomized sham-controlled study. Low Urin Tract Symptoms. 2017 Sep 29 doi: 10.1111/luts.12197. PMID: 28961380. [PubMed: 28961380] [CrossRef]

Zanetti MR, Castro Rde A, Rotta AL, et al. Impact of supervised physiotherapeutic pelvic floor exercises for treating female stress urinary incontinence. Sao Paulo Med J. 2007 Sep 06;125(5):265–9. PMID: 18094892. [PubMed: 18094892]

Abdelbary AM, El-Dessoukey AA, Massoud AM, et al. Combined Vaginal Pelvic Floor Electrical Stimulation (PFS) and Local Vaginal Estrogen for Treatment of Overactive Bladder (OAB) in Perimenopausal Females. Randomized Controlled Trial (RCT). Urology. 2015 Sep;86(3):482–6. doi: 10.1016/j.urology.2015.06.007. PMID: 26135813. [PubMed: 26135813] [CrossRef]

Abdulaziz K, Hasan T. Role of pelvic floor muscle therapy in obese perimenopausal females with stress incontinence: A randomized control trial. The Internet Journal of Gynecology and Obstetrics. 2012;16(2):34–42.

Ahlund S, Nordgren B, Wilander EL, et al. Is home-based pelvic floor muscle training effective in treatment of urinary incontinence after birth in primiparous women? A randomized controlled trial. Acta Obstet Gynecol Scand. 2013 Aug;92(8):909–15. doi: 10.1111/aogs.12173. PMID: 23672520. [PubMed: 23672520] [CrossRef]

Alves PG, Nunes FR, Guirro EC. Comparison between two different neuromuscular electrical stimulation protocols for the treatment of female stress urinary incontinence: a randomized controlled trial. Rev Bras Fisioter. 2011 Sep-Oct;15(5):393–8. PMID: 21860988. [PubMed: 21860988]

Beer GM, Gurule MM, Komesu YM, et al. Cycling Versus Continuous Mode In Neuromodulator Programming: A Crossover, Randomized, Controlled Trial. Urol Nurs. 2016 May-Jun;36(3):123–32. PMID: 27501593. [PMC free article: PMC5248562] [PubMed: 27501593]

Betschart C, Mol SE, Lutolf-Keller B, et al. Pelvic floor muscle training for urinary incontinence: a comparison of outcomes in premenopausal versus postmenopausal women. Female Pelvic Med Reconstr Surg. 2013 Jul-Aug;19(4):219–24. doi: 10.1097/SPV.0b013e31829950e5. PMID: 23797521. [PubMed: 23797521] [CrossRef]

Castellani D, Saldutto P, Galica V, et al. Low-Dose Intravaginal Estriol and Pelvic Floor Rehabilitation in Post-Menopausal Stress Urinary Incontinence. Urol Int. 2015;95(4):417–21. doi: 10.1159/000381989. PMID: 26043913. [PubMed: 26043913] [CrossRef]

Ferreira M, Santos PC, Duarte JA, et al. Exercise programmes for women with stress urinary incontinence: Margarida Ferreira and colleagues report on a randomised pilot study to evaluate home-based and supervised pelvic floor training. Primary Health Care. 2012;22(3):24–7.

Kaya S, Akbayrak T, Beksac S. Comparison of different treatment protocols in the treatment of idiopathic detrusor overactivity: a randomized controlled trial. Clin Rehabil. 2011 Apr;25(4):327–38. doi: 10.1177/0269215510385481. PMID: 20943711. [PubMed: 20943711] [CrossRef]

Labrie J, Berghmans BL, Fischer K, et al. Surgery versus physiotherapy for stress urinary incontinence. N Engl J Med. 2013 Sep 19;369(12):1124–33. doi: 10.1056/NEJMoa1210627. PMID: 24047061. [PubMed: 24047061] [CrossRef]

Peters KM, Shen L, McGuire M. Effect of Sacral Neuromodulation Rate on Overactive Bladder Symptoms: A Randomized Crossover Feasibility Study. Low Urin Tract Symptoms. 2013 Sep;5(3):129–33. doi: 10.1111/luts.12000. PMID: 26663447. [PubMed: 26663447] [CrossRef]

Resnick NM, Perera S, Tadic S, et al. What predicts and what mediates the response of urge urinary incontinence to biofeedback? Neurourol Urodyn. 2013 Jun;32(5):408–15. doi: 10.1002/nau.22347. PMID: 23168606. [PMC free article: PMC4850903] [PubMed: 23168606] [CrossRef]

Segal S, Morse A, Sangal P, et al. Efficacy of FemiScan Pelvic Floor Therapy for the Treatment of Urinary Incontinence. Female Pelvic Med Reconstr Surg. 2016 Nov/Dec;22(6):433–7. doi: 10.1097/spv.0000000000000307. PMID: 27636211. [PubMed: 27636211] [CrossRef]

Sherburn M, Bird M, Carey M, et al. Incontinence improves in older women after intensive pelvic floor muscle training: an assessor-blinded randomized controlled trial. Neurourol Urodyn. 2011 Mar;30(3):317–24. doi: 10.1002/nau.20968. PMID: 21284022. [PubMed: 21284022] [CrossRef]

Siegel S, Noblett K, Mangel J, et al. Three-year Follow-up Results of a Prospective, Multicenter Study in Overactive Bladder Subjects Treated With Sacral Neuromodulation. Urology. 2016 Aug;94:57–63. doi: 10.1016/j.urology.2016.04.024. PMID: 27131966. [PubMed: 27131966] [CrossRef]

Sjostrom M, Umefjord G, Stenlund H, et al. Internet-based treatment of stress urinary incontinence: a randomised controlled study with focus on pelvic floor muscle training. BJU Int. 2013 Aug;112(3):362–72. doi: 10.1111/j.1464-410X.2012.11713.x. PMID: 23350826. [PMC free article: PMC3798106] [PubMed: 23350826] [CrossRef]

Wang S, Lv J, Feng X, et al. Efficacy of Electrical Pudendal Nerve Stimulation versus Transvaginal Electrical Stimulation in Treating Female Idiopathic Urgency Urinary Incontinence. J Urol. 2017 Jun;197(6):1496–501. doi: 10.1016/j.juro.2017.01.065. PMID: 28153510. [PubMed: 28153510] [CrossRef]

Chughtai B, Forde JC, Buck J, et al. The concomitant use of fesoterodine and topical vaginal estrogen in the management of overactive bladder and sexual dysfunction in postmenopausal women. Post Reprod Health. 2016 Mar;22(1):34–40. doi: 10.1177/2053369116633017. PMID: 26883688. [PubMed: 26883688] [CrossRef]

Dede H, Dolen I, Dede FS, et al. What is the success of drug treatment in urge urinary incontinence? What should be measured? Arch Gynecol Obstet. 2013 Mar;287(3):511–8. doi: 10.1007/s00404-012-2596-8. PMID: 23086134. [PubMed: 23086134] [CrossRef]

Dmochowski RR, Davila GW, Zinner NR, et al. Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence. J Urol. 2002 Aug;168(2):580–6. PMID: 12131314. [PubMed: 12131314]

Huang AJ, Hess R, Arya LA, et al. Pharmacologic treatment for urgency-predominant urinary incontinence in women diagnosed using a simplified algorithm: a randomized trial. Am J Obstet Gynecol. 2012 May;206(5):444.e1–11. doi: 10.1016/j.ajog.2012.03.002. PMID: 22542122. [PMC free article: PMC3570031] [PubMed: 22542122] [CrossRef]

Marencak J, Cossons NH, Darekar A, et al. Investigation of the clinical efficacy and safety of pregabalin alone or combined with tolterodine in female subjects with idiopathic overactive bladder. Neurourol Urodyn. 2011 Jan;30(1):75–82. doi: 10.1002/nau.20928. PMID: 20886571. [PubMed: 20886571] [CrossRef]

Oreskovic S, But I, Banovic M, et al. The efficacy and safety of solifenacin in patients with overactive bladder syndrome. Coll Antropol. 2012 Mar;36(1):243–8. PMID: 22816227. [PubMed: 22816227]

Orri M, Lipset CH, Jacobs BP, et al. Web-based trial to evaluate the efficacy and safety of tolterodine ER 4 mg in participants with overactive bladder: REMOTE trial. Contemp Clin Trials. 2014 Jul;38(2):190–7. doi: 10.1016/j.cct.2014.04.009. PMID: 24792229. [PubMed: 24792229] [CrossRef]

Sand PK, Davila GW, Lucente VR, et al. Efficacy and safety of oxybutynin chloride topical gel for women with overactive bladder syndrome. Am J Obstet Gynecol. 2012 Feb;206(2):168.e1–6. doi: 10.1016/j.ajog.2011.08.005. PMID: 21963104. [PubMed: 21963104] [CrossRef]

Anderson RU, Mobley D, Blank B, et al. Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study Group. J Urol. 1999 Jun;161(6):1809–12. PMID: 10332441. [PubMed: 10332441]

Appell RA, Juma S, Wells WG, et al. Transurethral radiofrequency energy collagen micro-remodeling for the treatment of female stress urinary incontinence. Neurourol Urodyn. 2006;25(4):331–6. doi: 10.1002/nau.20185. PMID: 16673379. [PubMed: 16673379] [CrossRef]

Armstrong RB, Luber KM, Peters KM. Comparison of dry mouth in women treated with extended-release formulations of oxybutynin or tolterodine for overactive bladder. Int Urol Nephrol. 2005;37(2):247–52. doi: 10.1007/s11255-004-4703-7. PMID: 16142551. [PubMed: 16142551] [CrossRef]

Aziminekoo E, Ghanbari Z, Hashemi S, et al. Oxybutynin and tolterodine in a trial for treatment of overactive bladder in Iranian women. J Family Reprod Health. 2014 Jun;8(2):73–6. PMID: 24971138. [PMC free article: PMC4064768] [PubMed: 24971138]

Balachandran A, Duckett J. The efficacy and tolerability of mirabegron in a non-trial clinical setting. Eur J Obstet Gynecol Reprod Biol. 2016 May;200:63–7. doi: 10.1016/j.ejogrb.2016.02.030. PMID: 26978321. [PubMed: 26978321] [CrossRef]

Bodeker RH, Madersbacher H, Neumeister C, et al. Dose escalation improves therapeutic outcome: post hoc analysis of data from a 12-week, multicentre, double-blind, parallel-group trial of trospium chloride in patients with urinary urge incontinence. BMC Urol. 2010 Sep 14;10:15. doi: 10.1186/1471-2490-10-15. PMID: 20840754. [PMC free article: PMC2945343] [PubMed: 20840754] [CrossRef]

Bray R, Cartwright R, Cardozo L, et al. Tolterodine ER reduced increased bladder wall thickness in women with overactive bladder. A randomized, placebo-controlled, double-blind, parallel group study. Neurourol Urodyn. 2017 Apr 13 doi: 10.1002/nau.23281. PMID: 28407338. [PubMed: 28407338] [CrossRef]

Butt F, Badar N, Rana M. Comparison of Side Effects of Solifenacin Vs Tolteridine in Patients with Urinary Incontinence. PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES. 2016;10(2):590–3.

Castro-Diaz D, Palma PC, Bouchard C, et al. Effect of dose escalation on the tolerability and efficacy of duloxetine in the treatment of women with stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2007 Aug;18(8):919–29. doi: 10.1007/s00192-006-0256-x. PMID: 17160693. [PubMed: 17160693] [CrossRef]

Chu FM, Dmochowski RR, Lama DJ, et al. Extended-release formulations of oxybutynin and tolterodine exhibit similar central nervous system tolerability profiles: a subanalysis of data from the OPERA trial. Am J Obstet Gynecol. 2005 Jun;192(6):1849–54; discussion 54–5. doi: 10.1016/j.ajog.2005.03.036. PMID: 15970828. [PubMed: 15970828] [CrossRef]

Davila GW, Daugherty CA, Sanders SW. A short-term, multicenter, randomized double-blind dose titration study of the efficacy and anticholinergic side effects of transdermal compared to immediate release oral oxybutynin treatment of patients with urge urinary incontinence. J Urol. 2001 Jul;166(1):140–5. PMID: 11435842. [PubMed: 11435842]

Dmochowski R, Chapple C, Nitti VW, et al. Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. J Urol. 2010 Dec;184(6):2416–22. doi: 10.1016/j.juro.2010.08.021. PMID: 20952013. [PubMed: 20952013] [CrossRef]

Dmochowski RR, Miklos JR, Norton PA, et al. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. J Urol. 2003 Oct;170(4 Pt 1):1259–63. doi: 10.1097/01.ju.0000080708.87092.cc. PMID: 14501737. [PubMed: 14501737] [CrossRef]

Dmochowski RR, Sand PK, Zinner NR, et al. Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence. Urology. 2003 Aug;62(2):237–42. PMID: 12893326. [PubMed: 12893326]

Dmochowski RR, Staskin DR, Duchin K, et al. Clinical safety, tolerability and efficacy of combination tolterodine/pilocarpine in patients with overactive bladder. Int J Clin Pract. 2014 Aug;68(8):986–94. doi: 10.1111/ijcp.12409. PMID: 24666884. [PubMed: 24666884] [CrossRef]

Frenkl T, Railkar R, Shore N, et al. Evaluation of an experimental urodynamic platform to identify treatment effects: a randomized, placebo-controlled, crossover study in patients with overactive bladder. Neurourol Urodyn. 2012 Jan;31(1):69–74. doi: 10.1002/nau.21094. PMID: 21905086. [PubMed: 21905086] [CrossRef]

Futyma K, Miotla P, Galczynski K, et al. An Open Multicenter Study of Clinical Efficacy and Safety of Urolastic, an Injectable Implant for the Treatment of Stress Urinary Incontinence: One-Year Observation. Biomed Res Int. 2015;2015:851823. doi: 10.1155/2015/851823. PMID: 26106616. [PMC free article: PMC4461699] [PubMed: 26106616] [CrossRef]

Gameiro MO, Moreira EH, Gameiro FO, et al. Vaginal weight cone versus assisted pelvic floor muscle training in the treatment of female urinary incontinence. A prospective, single-blind, randomized trial. Int Urogynecol J. 2010 Apr;21(4):395–9. doi: 10.1007/s00192-009-1059-7. PMID: 20052573. [PubMed: 20052573] [CrossRef]

Ghoniem GM, Van Leeuwen JS, Elser DM, et al. A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence. J Urol. 2005 May;173(5):1647–53. doi: 10.1097/01.ju.0000154167.90600.c6. PMID: 15821528. [PubMed: 15821528] [CrossRef]

Gupta SK, Sathyan G. Pharmacokinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin. J Clin Pharmacol. 1999 Mar;39(3):289–96. PMID: 10073329. [PubMed: 10073329]

Gupta SK, Sathyan G, Lindemulder EA, et al. Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships. Clin Pharmacol Ther. 1999 Jun;65(6):672–84. doi: 10.1016/s0009-9236(99)90089-9. PMID: 10391673. [PubMed: 10391673] [CrossRef]

Hess R, Huang AJ, Richter HE, et al. Long-term efficacy and safety of questionnaire-based initiation of urgency urinary incontinence treatment. Am J Obstet Gynecol. 2013 Sep;209(3):244.e1–9. doi: 10.1016/j.ajog.2013.05.008. PMID: 23659987. [PMC free article: PMC4019400] [PubMed: 23659987] [CrossRef]

Homma Y, Paick JS, Lee JG, et al. Clinical efficacy and tolerability of extended-release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with an overactive bladder: a randomized, placebo-controlled trial. BJU Int. 2003 Nov;92(7):741–7. PMID: 14616458. [PubMed: 14616458]

Hurley DJ, Turner CL, Yalcin I, et al. Duloxetine for the treatment of stress urinary incontinence in women: an integrated analysis of safety. Eur J Obstet Gynecol Reprod Biol. 2006 Mar 01;125(1):120–8. doi: 10.1016/j.ejogrb.2005.08.006. PMID: 16188367. [PubMed: 16188367] [CrossRef]

Jafarabadi M, Jafarabadi L, Shariat M, et al. Considering the prominent complaint as a guide in medical therapy for overactive bladder syndrome in women over 45 years. J Obstet Gynaecol Res. 2015 Jan;41(1):120–6. doi: 10.1111/jog.12483. PMID: 25369726. [PubMed: 25369726] [CrossRef]

Kinjo M, Sekiguchi Y, Yoshimura Y, et al. Long-term Persistence with Mirabegron versus Solifenacin in Women with Overactive Bladder: Prospective, Randomized Trial. Low Urin Tract Symptoms. 2016 Dec 02 doi: 10.1111/luts.12151. PMID: 27911988. [PubMed: 27911988] [CrossRef]

Klarskov N, Darekar A, Scholfield D, et al. Effect of fesoterodine on urethral closure function in women with stress urinary incontinence assessed by urethral pressure reflectometry. Int Urogynecol J. 2014 Jun;25(6):755–60. doi: 10.1007/s00192-013-2269-6. PMID: 24258099. [PubMed: 24258099] [CrossRef]

Lightner D, Rovner E, Corcos J, et al. Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigen cystoscopically. Urology. 2009 Oct;74(4):771–5. doi: 10.1016/j.urology.2009.05.034. PMID: 19660800. [PubMed: 19660800] [CrossRef]

Michel MC, Minarzyk A, Schwerdtner I, et al. Observational study on safety and tolerability of duloxetine in the treatment of female stress urinary incontinence in German routine practice. Br J Clin Pharmacol. 2013 Apr;75(4):1098–108. doi: 10.1111/j.1365-2125.2012.04389.x. PMID: 22816871. [PMC free article: PMC3612728] [PubMed: 22816871] [CrossRef]

Mohr S, Marthaler C, Imboden S, et al. Bulkamid (PAHG) in mixed urinary incontinence: What is the outcome? Int Urogynecol J. 2017 Apr 17 doi: 10.1007/s00192-017-3332-5. PMID: 28417154. [PubMed: 28417154] [CrossRef]

Mohr S, Siegenthaler M, Mueller MD, et al. Bulking agents: an analysis of 500 cases and review of the literature. Int Urogynecol J. 2013 Feb;24(2):241–7. doi: 10.1007/s00192-012-1834-8. PMID: 22707004. [PubMed: 22707004] [CrossRef]

Nitti VW, Ginsberg D, Sievert KD, et al. Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study. J Urol. 2016 Sep;196(3):791–800. doi: 10.1016/j.juro.2016.03.146. PMID: 27038769. [PubMed: 27038769] [CrossRef]

Pai A, Al-Singary W. Durability, safety and efficacy of polyacrylamide hydrogel (Bulkamid((R))) in the management of stress and mixed urinary incontinence: three year follow up outcomes. Cent European J Urol. 2015;68(4):428–33. doi: 10.5173/ceju.2015.647. PMID: 26855795. [PMC free article: PMC4742441] [PubMed: 26855795] [CrossRef]

Preik M, Albrecht D, O’Connell M, et al. Effect of controlled-release delivery on the pharmacokinetics of oxybutynin at different dosages: severity-dependent treatment of the overactive bladder. BJU Int. 2004 Oct;94(6):821–7. doi: 10.1111/j.1464-410X.2004.05040.x. PMID: 15476516. [PubMed: 15476516] [CrossRef]

Robinson D, Abrams P, Cardozo L, et al. The efficacy and safety of PSD503 (phenylephrine 20%, w/w) for topical application in women with stress urinary incontinence. A phase II, multicentre, double-blind, placebo controlled, 2-way cross over study. Eur J Obstet Gynecol Reprod Biol. 2011 Dec;159(2):457–60. doi: 10.1016/j.ejogrb.2011.07.030. PMID: 21831512. [PubMed: 21831512] [CrossRef]

Saks EK, Wiebe DJ, Cory LA, et al. Beliefs about medications as a predictor of treatment adherence in women with urinary incontinence. J Womens Health (Larchmt). 2012 Apr;21(4):440–6. doi: 10.1089/jwh.2011.2952. PMID: 22288516. [PubMed: 22288516] [CrossRef]

Salvatore S, Khullar V, Cardozo L, et al. Long-term prospective randomized study comparing two different regimens of oxybutynin as a treatment for detrusor overactivity. Eur J Obstet Gynecol Reprod Biol. 2005 Apr 01;119(2):237–41. doi: 10.1016/j.ejogrb.2004.07.042. PMID: 15808387. [PubMed: 15808387] [CrossRef]

Sand PK, Dmochowski RR, Zinner NR, et al. Trospium chloride extended release is effective and well tolerated in women with overactive bladder syndrome. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Dec;20(12):1431–8. doi: 10.1007/s00192-009-0969-8. PMID: 19727537. [PubMed: 19727537] [CrossRef]

Sand PK, Miklos J, Ritter H, et al. A comparison of extended-release oxybutynin and tolterodine for treatment of overactive bladder in women. Int Urogynecol J Pelvic Floor Dysfunct. 2004 Jul-Aug;15(4):243–8. PMID: 15517668. [PubMed: 15517668]

Sokol ER, Karram MM, Dmochowski R. Efficacy and safety of polyacrylamide hydrogel for the treatment of female stress incontinence: a randomized, prospective, multicenter North American study. J Urol. 2014 Sep;192(3):843–9. doi: 10.1016/j.juro.2014.03.109. PMID: 24704117. [PubMed: 24704117] [CrossRef]

Sung HH, Han DH, Kim TH, et al. Interventions do not enhance medication persistence and compliance in patients with overactive bladder: a 24 weeks, randomised, open-label, multi-center trial. Int J Clin Pract. 2015 Nov;69(11):1309–15. doi: 10.1111/ijcp.12705. PMID: 26215431. [PubMed: 26215431] [CrossRef]

Swift S, Garely A, Dimpfl T, et al. A new once-daily formulation of tolterodine provides superior efficacy and is well tolerated in women with overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct. 2003 Feb;14(1):50–4; discussion 4–5. doi: 10.1007/s00192-002-1009-0. PMID: 12601517. [PubMed: 12601517] [CrossRef]

Tapp AJ, Cardozo LD, Versi E, et al. The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: a double blind placebo controlled study. Br J Obstet Gynaecol. 1990 Jun;97(6):521–6. PMID: 2198921. [PubMed: 2198921]

Toozs-Hobson P, Al-Singary W, Fynes M, et al. Two-year follow-up of an open-label multicenter study of polyacrylamide hydrogel (Bulkamid(R)) for female stress and stress-predominant mixed incontinence. Int Urogynecol J. 2012 Oct;23(10):1373–8. doi: 10.1007/s00192-012-1761-8. PMID: 22531952. [PMC free article: PMC3448051] [PubMed: 22531952] [CrossRef]

Zellner M, Madersbacher H, Palmtag H, et al. Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial. Clin Ther. 2009 Nov;31(11):2519–39. doi: 10.1016/j.clinthera.2009.11.005. PMID: 20109997. [PubMed: 20109997] [CrossRef]

Zimmern P, Litman HJ, Mueller E, et al. Effect of fluid management on fluid intake and urge incontinence in a trial for overactive bladder in women. BJU Int. 2010 Jun;105(12):1680–5. doi: 10.1111/j.1464-410X.2009.09055.x. PMID: 19912207. [PMC free article: PMC3723332] [PubMed: 19912207] [CrossRef]

Zinner N, Tuttle J, Marks L. Efficacy and tolerability of darifenacin, a muscarinic M3 selective receptor antagonist (M3 SRA), compared with oxybutynin in the treatment of patients with overactive bladder. World J Urol. 2005 Sep;23(4):248–52. doi: 10.1007/s00345-005-0507-3. PMID: 16096831. [PubMed: 16096831] [CrossRef]

Nelken RS, Ozel BZ, Leegant AR, et al. Randomized trial of estradiol vaginal ring versus oral oxybutynin for the treatment of overactive bladder. Menopause. 2011 Sep;18(9):962–6. doi: 10.1097/gme.0b013e3182104977. PMID: 21532512. [PubMed: 21532512] [CrossRef]

Milani AL, Flu PK, Vierhout ME, et al. [Results and complications of vaginal correction of vaginal and uterine prolapse with or without urinary incontinence; a prospective study]. Ned Tijdschr Geneeskd. 1993 Jan 30;137(5):250–5. PMID: 8433761. [PubMed: 8433761]

Ozdedeli S, Karapolat H, Akkoc Y. Comparison of intravaginal electrical stimulation and trospium hydrochloride in women with overactive bladder syndrome: a randomized controlled study. Clin Rehabil. 2010 Apr;24(4):342–51. doi: 10.1177/0269215509346092. PMID: 20212061. [PubMed: 20212061] [CrossRef]

Lose G, Englev E. Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms. Bjog. 2000 Aug;107(8):1029–34. PMID: 10955437. [PubMed: 10955437]

Risacher SL, McDonald BC, Tallman EF, et al. Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults. JAMA Neurol. 2016 Jun 01;73(6):721–32. doi: 10.1001/jamaneurol.2016.0580. PMID: 27088965. [PMC free article: PMC5029278] [PubMed: 27088965] [CrossRef]

Gray SL, Anderson ML, Dublin S, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015 Mar;175(3):401–7. doi: 10.1001/jamainternmed.2014.7663. PMID: 25621434. [PMC free article: PMC4358759] [PubMed: 25621434] [CrossRef]

Jessen F, Kaduszkiewicz H, Daerr M, et al. Anticholinergic drug use and risk for dementia: target for dementia prevention. Eur Arch Psychiatry Clin Neurosci. 2010 Nov;260: Suppl 2:S111–5. doi: 10.1007/s00406-010-0156-4. PMID: 20960005. [PubMed: 20960005] [CrossRef]

Carriere I, Fourrier-Reglat A, Dartigues JF, et al. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med. 2009 Jul 27;169(14):1317–24. doi: 10.1001/archinternmed.2009.229. PMID: 19636034. [PMC free article: PMC2933398] [PubMed: 19636034] [CrossRef]

Ancelin ML, Artero S, Portet F, et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. Bmj. 2006 Feb 25;332(7539):455–9. doi: 10.1136/bmj.38740.439664.DE. PMID: 16452102. [PMC free article: PMC1382539] [PubMed: 16452102] [CrossRef]

Puhan MA, Schunemann HJ, Murad MH, et al. A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis. Bmj. 2014 Sep 24;349:g5630. doi: 10.1136/bmj.g5630. PMID: 25252733. [PubMed: 25252733] [CrossRef]

Salanti G, Del Giovane C, Chaimani A, et al. Evaluating the quality of evidence from a network meta-analysis. PLoS One. 2014;9(7):e99682. doi: 10.1371/journal.pone.0099682. PMID: 24992266. [PMC free article: PMC4084629] [PubMed: 24992266] [CrossRef]

Bo K. Urinary incontinence, pelvic floor dysfunction, exercise and sport. Sports Med. 2004;34(7):451–64. PMID: 15233598. [PubMed: 15233598]

Robinson D, Castro-Diaz D, Giarenis I, et al. What is the best surgical intervention for stress urinary incontinence in the very young and very old? An International Consultation on Incontinence Research Society update. Int Urogynecol J. 2015 Nov;26(11):1599–604. doi: 10.1007/s00192-015-2783-9. PMID: 26202394. [PubMed: 26202394] [CrossRef]